Argan INC Form 4 insider transactions

NYSE
Richard H. Deily, Compliance Officer and former CFO of Argan Inc., sold 1,565 shares of common stock on April 30, 2025.
NYSE
Charles Collins IV, CEO of Argan Inc., reports the vesting of restricted stock units and the grant of new stock options and restricted stock units based on time, renewable energy projects, total stock return, and earnings per share performance.
NYSE
Director Rainer H. Bosselmann reports the vesting of time-based and performance-based restricted stock units, resulting in the acquisition of Argan Inc. common stock.
NYSE
David Watson, President and CEO of Argan Inc., reports stock sales, vesting of restricted stock units, and grants of new restricted stock units and stock options.
NYSE
Director Peter W. Getsinger exercised stock options and sold shares of Argan Inc. common stock in a series of transactions on April 14 and April 16, 2025.
NYSE
William F. Griffin Jr., a director and Non-Executive Chairman (GEMMA) of Argan Inc., transferred 130,000 shares of common stock to the William F. Griffin 2025 GRAT Trust on April 10, 2025.
NYSE
Rainer H. Bosselmann, a director at Argan Inc. (AGX), sold 25,000 shares of common stock at an average price of $129.35 per share on April 1, 2025.
NYSE
Director Cynthia Flanders sold 4,092 shares of Argan Inc. (AGX) on April 2, 2025, at an average price of $133.64 per share.
NYSE
James W. Quinn, a director of Argan Inc., transferred 63,014 shares of common stock to the James W. Quinn 2025 GRAT No.1 on March 17, 2025.
NYSE
William F. Leimkuhler, a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $30.44 per share on January 21, 2025, using the net settle method, resulting in changes to his beneficial ownership.
NYSE
John R. Jeffrey, Jr., a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $40.15 per share on January 17, 2025.
NYSE
Director Peter W. Getsinger exercised stock options and sold shares of Argan Inc. common stock in a series of transactions in January 2025.
NYSE
Richard H. Deily, Compliance Officer and former CFO of Argan Inc., sold 2,000 shares of the company's common stock on January 8, 2025.
NYSE
Argan Inc. director, Jeffrey John Ronald Jr., sold 5,000 shares of common stock on the open market at an average price of $138.99 per share.
NYSE
Director Peter W. Getsinger reported donating a total of 2,000 shares of Argan Inc. (AGX) common stock on December 24, 2024.
NYSE
John R. Jeffrey, Jr., a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $41.19 per share on December 20, 2024.
NYSE
Argan Inc.'s CEO, David Watson, exercised stock options, sold shares on the open market, and gifted shares to a foundation on December 18, 2024.
NYSE
Director William F. Leimkuhler of Argan Inc. reported the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
Director Karen Sweeney of Argan Inc. was granted 388 time-based restricted stock units (TRSUs) that will vest on June 10, 2025.
NYSE
Director John R. Jeffrey Jr. of Argan Inc. reports the vesting of restricted stock units and a new grant of restricted stock units.
NYSE
Director Cynthia Flanders of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
Director Peter W. Getsinger of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
Director James W. Quinn of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
A Form 4 filing reveals changes in beneficial ownership of Argan Inc. stock and derivative securities held by the estate of deceased director, W.G. Champion Mitchell.
NYSE
Director Peter W. Getsinger reported a transfer of 1,000 shares of Argan Inc. common stock to a donor advised fund on October 31, 2024.
NYSE
William F. Griffin Jr., a director at Argan Inc., reported that the Peach Pit Foundation, of which his wife is the trustee, sold 7,500 shares of Argan Inc. common stock.
NYSE
William F. Griffin Jr., a director at Argan Inc., reports donating 5,000 shares of Argan Inc. common stock to the Peach Pit Foundation.
NYSE
Director Rainer H. Bosselmann reports selling shares of Argan Inc. (AGX) common stock over three days in October 2024.
NYSE
Director Cynthia Flanders sold 5,000 shares of Argan Inc. (AGX) common stock on September 25, 2024, at an average price of $96.3888.
NYSE
Director Rainer H. Bosselmann exercised stock options to purchase Argan Inc. common stock at various prices on September 23, 2024.